2007 Bmw 650 I on 2040-cars

Auto blog

This BMW 2 Series ad has run afoul of Aussie ad watchdogs [w/poll]

A complaint by an Australian movie-goer has put the brakes on an extended in-theater ad campaign by BMW, and drawn the attention of the country's Advertising Standards Board. According to the anonymous complaint, the ad "portrays an unfavorable message, contrary to safe and sensible driving."
The ASB upheld the complaint, which said the ad for the new M235i showed driving "typical of hoon activity," thanks to the burnouts, dusty drifts and runs up to redline. It's that last one that seems to have gotten the spot in the most trouble, with the ASB acknowledging that even though the car wasn't shown breaking the speed limit, the ad was in violation of a voluntary code of conduct for automotive advertising, according to Australia's Go Auto.
BMW doesn't seem to agree, pointing out that the ad uses creative editing, aggressive camera angles and other filming tricks to "add visual impact."

BMW celebrates 30 years of M5 with 600-hp super sedan

It's been 30 years since BMW rolled out the first M5, and while displacement and cylinder count may have fluctuated over those past three decades, output has only increased. The first-generation E28 M5 packed a 3.5-liter inline-six with 252 horsepower and 243 lb-ft of torque. The second-gen E34 model that followed added an extra 100 cc (and later 200 more) to produce 310 hp and 266 lb-ft. The E39 followed with a 4.9-liter V8 churning out 394 hp and 369 lb-ft, replaced by the award-winning 5.0-liter V10 in the E60 with its 500 hp and 380 lb-ft before BMW rolled out the latest model with a 4.4-liter V8, its twin turbos making up for the two dropped cylinders and 600 cc of displacement to produce 560 hp and 502 lb-ft of torque. But even that's being left in the dust by the new special edition you see here.
The 30th Anniversary Edition BMW M5 packs that same 4.4-liter twin-turbo V8, but cranks the output up to a nice, round 600 horsepower and a solid 516 lb-ft of torque to go with it. That makes it more powerful, not only than any M5 that's come before it, but also any of its rivals. The Jaguar XFR-S and Audi RS6 Avant (the latter only available as a wagon and not in North America) both lag behind this ultimate of Ultimate Driving Machines; only the Mercedes-Benz E63 AMG trumps it on torque (but not on power), with 531 lb-ft in stock form and 590 in the S-Model.
As a result, the 0-60 time drops from a quoted 4.2 seconds in the stock M5 to a scant 3.7 in the 30th Anniversary edition (just one tick behind that twistier E63 S). The special M5 also comes with the Competition Package as standard, as well as a dedicated control module for the Active M Differential, a special Frozen Dark Silver matte finish, 20-inch alloys and black chrome badges. Special badges abound inside as well, where you'll also find black leather and Alcantara upholstery and aluminum trim. There'll even be a dedicated one-day course offered to owners at The Thermal Club in Palm Springs, CA, to further sweeten the deal.

BMW Active Tourer to hit US showrooms in 2015

It's been over a year since BMW unveiled the Concept Active Tourer at the Paris Motor Show, and another four months since it brought the concept back in Outdoor guise (pictured above). Now word has it that the Bavarian automaker is putting it into production.
Although production specs and dimensions have yet to be revealed, the Concept Active Tourer came in a bit smaller than the existing BMW X1. The production version is expected to be based on the same platform that underpins the new Mini hatchback revealed last week in LA, meaning that it will be predominantly front-drive, but an all-wheel-drive version could follow.
There will also be a longer version with a third row of seats, forming part of a new generation of front-drive BMWs to take on the likes of the Audi A1 and Mercedes-Benz A-Class family, of which the GLA will be the Active Tourer's most direct rival. Expect the Active Tourer to arrive in 2015 with a new front-drive sedan to follow in 2017 aimed particularly at the North American and Chinese markets.